Publication: 3923

Publication: 3923

PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by Total Mesorectal Excision (TME) for treatment of locally advanced rectal cancer (LARC). (Alliance N1048)

DOI

URL

Google Scholar

Citation:: JCO vol 41 (suppl 17) LBA2

Meeting Instance:: ASCO 2023
Year:: 2023
Type:: Abstract
Sub type:: Plenary
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 4015

Program:: OGC
Primary Committee:: GI
Sec. Committees:: CRP

Pharmas:
Grants:: U10CA180821, U10CA180882; U10CA180863 (CCTG); U10CA180820 (ECOG-ACRIN); U10CA180868 (NRG); U10CA180888 (SWOG)

Corr. Author:
Authors:: Deborah Schrag Qian Shi Martin Weiser Marc Gollub Leonard Saltz George Chang Rebecca Auer Jeffrey Farma Thom George Hagen Kennecke Benjamin Musher Joel Goldberg Tareq Al baghdadi AmyLou Dueck Ethan Basch Alan Venook Karyn Goodman Eileen O'Reilly Jeffrey Meyerhardt Harvey Mamon

Networks:: CA824, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NY016, LAPS-TX035, MCRC, NY021, OR013, PA086

Study: NCCTG-N1048
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2/3

Keywords: